Cargando…

Hepatitis B seroconversion revisited: new insights into the natural history of acute hepatitis B virus (HBV) infection from quantitative and highly sensitive assays and novel biomarkers

BACKGROUND: Hepatitis B virus (HBV) serum markers during typical acute self-limited infection are usually depicted as a composite of traditional HBV markers. The current study updates and expands our knowledge of acute hepatitis B with quantitative molecular and serological data on longitudinal samp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuhns, Mary C., Holzmayer, Vera, McNamara, Anne L., Anderson, Mark, Cloherty, Gavin A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628455/ https://www.ncbi.nlm.nih.gov/pubmed/34844619 http://dx.doi.org/10.1186/s12985-021-01706-w

Ejemplares similares

Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen
por: Kuhns, Mary C., et al.
Publicado: (2021)

Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors
por: Kuhns, Mary C., et al.
Publicado: (2019)

Identification of hepatitis B virus genotype I in Thailand
por: Holzmayer, Vera, et al.
Publicado: (2018)

Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139‐Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection
por: Bazinet, Michel, et al.
Publicado: (2020)

Evaluation of hepatitis C virus antibody assay using dried blood spot samples
por: Holzmayer, Vera, et al.
Publicado: (2022)

Measuring hepatitis B pgRNA stability using an updated automated HBV pgRNA assay with increased sensitivity
por: Anderson, Mark, et al.
Publicado: (2023)

Quantitative HBsAg and HBeAg Predict Hepatitis B Seroconversion after Initiation of HAART in HIV-HBV Coinfected Individuals
por: Matthews, Gail V., et al.
Publicado: (2013)

More DNA and RNA of HBV SP1 splice variants are detected in genotypes B and C at low viral replication
por: Luk, Ka-Cheung, et al.
Publicado: (2021)

Dilemma of HBsAg seroconversion in chronic hepatitis B infection: Dilemma of HBsAg in chronic HBV
por: Alavian, Seyed Moayed, et al.
Publicado: (2011)

Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America
por: Ghany, Marc G., et al.
Publicado: (2021)

HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection
por: Bazinet, Michel, et al.
Publicado: (2022)

A standardized assay for the quantitative detection of serum HBV RNA in chronic hepatitis B patients
por: Yu, Guangxin, et al.
Publicado: (2022)

Characterization of HBV surface antigen isoforms in the natural history and treatment of HBV infection
por: Rodgers, Mary A., et al.
Publicado: (2023)

Seroconversion of Hepatitis B Virus Surface Antigen in Chronic Hepatitis B Child Treated with Entecavir
por: Li, Dong, et al.
Publicado: (2012)

Expanding access to SARS-CoV-2 IgG and IgM serologic testing using fingerstick whole blood, plasma, and rapid lateral flow assays
por: Anderson, Mark, et al.
Publicado: (2021)

Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response
por: Cloherty, Gavin, et al.
Publicado: (2016)

Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues
por: Wang, Yang, et al.
Publicado: (2022)

HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients
por: Song, Guangjun, et al.
Publicado: (2023)

Prediction for HBsAg seroconversion in children with chronic hepatitis B
por: Zhong, Yan-Wei, et al.
Publicado: (2021)

Seroconversion of Hepatitis B Envelope Antigen (HBeAg) by Entecavir in a Child with Chronic Hepatitis B
por: Hasosah, Mohammed Y., et al.
Publicado: (2012)

Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B
por: Chi, Xiu-Mei, et al.
Publicado: (2021)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
por: Gozlan, Yael, et al.
Publicado: (2022)

Hepatitis B e Antigen Seroconversion Is Related with the Function of Dendritic Cells in Chronic Hepatitis B Virus Infection
por: Lin, Chunjing, et al.
Publicado: (2014)

Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV Markers
por: Salpini, Romina, et al.
Publicado: (2020)

Management Of Patients With Hepatitis B Virus Reactivation Post–DAA Treatment Of Chronic Hepatitis C Virus Infection In HCV–HBV Coinfected Patients With Pretreatment HBeAg Seroconversion And Early Degree Of Hepatic Fibrosis
por: Osman, Heba Ahmed, et al.
Publicado: (2019)

HBS Ag seroclearance and seroconversion time in Patients with chronic hepatitis B Infection
por: Masrour-Roudsari, Jila, et al.
Publicado: (2020)

Seroconversion of hepatitis B vaccine among patients from outpatient clinic in Georgia
por: Kanchelashvili, Giorgi, et al.
Publicado: (2023)

Performance Evaluation of the Beckman Coulter DxN VERIS Hepatitis B Virus (HBV) Assay in Comparison With the Abbott RealTime HBV Assay
por: Park, Joonhong, et al.
Publicado: (2019)

Comparison of Amplix® hepatitis B virus and Roche COBAS AmpliPrep/COBAS Taqman hepatitis B virus assay in quantifying HBV DNA in plasma of chronic hepatitis B in Senegal
por: Lô, Gora, et al.
Publicado: (2021)

Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection
por: Liu, Yayun, et al.
Publicado: (2019)

Evaluation of the in situ assay for HBV DNA: An observational real-world study in chronic hepatitis B
por: Li, Chang, et al.
Publicado: (2021)

Universal Emergence of Precore Mutant Hepatitis B Virus along with Seroconversion to Anti-HBe Irrespective of Subsequent Activity of Chronic Hepatitis B
por: Koh, Kwang Cheol, et al.
Publicado: (1994)

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues
por: Fan, Rong, et al.
Publicado: (2016)

Hepatitis B: Knowledge, Vaccine Situation and Seroconversion of Dentistry Students of a Public University
por: Sacchetto, Marina Sena Lopes da Silva, et al.
Publicado: (2013)

Sequence analysis of integrated hepatitis B virus DNA during HBeAg-seroconversion
por: Budzinska, Magdalena Agnieszka, et al.
Publicado: (2018)

Predicting hepatitis B e Antigen seroconversion after pregnancy—The SydPregScore
por: Thilakanathan, Cynthuja, et al.
Publicado: (2022)

Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection
por: Liu, Zhihua, et al.
Publicado: (2006)

Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV
por: Vanwolleghem, Thomas, et al.
Publicado: (2021)

Performance evaluation of ExiStation HBV diagnostic system for hepatitis B virus DNA quantitation
por: Cha, Young Joo, et al.
Publicado: (2013)

Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients
por: Luo, Hao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dvjmuj0aa136h9tnq911lnr0f5